Financials New Nordic Healthbrands AB

Equities

NNH

SE0001838038

Food Processing

Delayed Nasdaq Stockholm 11:28:58 15/05/2024 BST 5-day change 1st Jan Change
19 SEK -2.06% Intraday chart for New Nordic Healthbrands AB +2.15% +14.11%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 421.3 501.8 351.9 547.7 179.7 103.2
Enterprise Value (EV) 1 409.5 501 343 560.2 217.3 116
P/E ratio 15.9 x 17.9 x 19.8 x 25.7 x -63.6 x -16.7 x
Yield 2.21% 2.16% 2.64% 1.41% - -
Capitalization / Revenue 1.07 x 1.11 x 0.78 x 1.06 x 0.37 x 0.19 x
EV / Revenue 1.04 x 1.11 x 0.76 x 1.09 x 0.45 x 0.22 x
EV / EBITDA 11.7 x 13.6 x 14 x 19.1 x -59.1 x -59.7 x
EV / FCF 36.4 x -48.2 x 19.2 x -33.8 x -13 x 3.86 x
FCF Yield 2.75% -2.07% 5.2% -2.95% -7.67% 25.9%
Price to Book 5.25 x 4.92 x 3.36 x 4.55 x 1.6 x 0.97 x
Nbr of stocks (in thousands) 6,195 6,195 6,195 6,195 6,195 6,195
Reference price 2 68.00 81.00 56.80 88.40 29.00 16.65
Announcement Date 28/03/19 27/03/20 26/03/21 25/03/22 27/03/23 28/03/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 393.7 452.6 450.1 514.8 487.5 533.8
EBITDA 1 34.86 36.86 24.46 29.34 -3.68 -1.944
EBIT 1 34.22 36.3 23.84 28.55 -4.749 -3.166
Operating Margin 8.69% 8.02% 5.3% 5.54% -0.97% -0.59%
Earnings before Tax (EBT) 1 34.12 36.07 23.29 27.96 -5.166 -5.914
Net income 1 26.52 28.07 17.76 21.3 -2.823 -6.194
Net margin 6.74% 6.2% 3.95% 4.14% -0.58% -1.16%
EPS 2 4.281 4.532 2.868 3.439 -0.4557 -0.9998
Free Cash Flow 1 11.26 -10.39 17.84 -16.55 -16.66 30.01
FCF margin 2.86% -2.3% 3.96% -3.22% -3.42% 5.62%
FCF Conversion (EBITDA) 32.3% - 72.93% - - -
FCF Conversion (Net income) 42.45% - 100.44% - - -
Dividend per Share 2 1.500 1.750 1.500 1.250 - -
Announcement Date 28/03/19 27/03/20 26/03/21 25/03/22 27/03/23 28/03/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 12.5 37.6 12.8
Net Cash position 1 11.7 0.85 8.84 - - -
Leverage (Debt/EBITDA) - - - 0.4275 x -10.23 x -6.599 x
Free Cash Flow 1 11.3 -10.4 17.8 -16.6 -16.7 30
ROE (net income / shareholders' equity) 37.6% 30.8% 17.2% 18.9% -2.42% -5.67%
ROA (Net income/ Total Assets) 14.2% 12.6% 7.67% 8.3% -1.21% -0.79%
Assets 1 186.9 222.6 231.7 256.6 233 783.8
Book Value Per Share 2 12.90 16.50 16.90 19.40 18.20 17.10
Cash Flow per Share 2 2.320 1.750 1.680 1.920 1.730 2.230
Capex 1 0.88 0.94 0.75 1.06 1.59 2.14
Capex / Sales 0.22% 0.21% 0.17% 0.2% 0.33% 0.4%
Announcement Date 28/03/19 27/03/20 26/03/21 25/03/22 27/03/23 28/03/24
1SEK in Million2SEK
Estimates
  1. Stock Market
  2. Equities
  3. NNH Stock
  4. Financials New Nordic Healthbrands AB